Monden Y - Search Results

1

Distinct repair activities of human 7,8-dihydro-8-oxoguanine DNA glycosylase and formamidopyrimidine DNA glycosylase for formamidopyrimidine and 7,8-dihydro-8-oxoguanine.

Asagoshi K, Yamada T, Terato H, Ohyama Y, Monden Y, Arai T, Nishimura S, Aburatani H, Lindahl T, Ide H. Asagoshi K, et al. Among authors: monden y. J Biol Chem. 2000 Feb 18;275(7):4956-64. doi: 10.1074/jbc.275.7.4956. J Biol Chem. 2000. PMID: 10671534 Free article.

2

Human MMH (OGG1) type 1a protein is a major enzyme for repair of 8-hydroxyguanine lesions in human cells.

Monden Y, Arai T, Asano M, Ohtsuka E, Aburatani H, Nishimura S. Monden Y, et al. Biochem Biophys Res Commun. 1999 May 19;258(3):605-10. doi: 10.1006/bbrc.1999.0649. Biochem Biophys Res Commun. 1999. PMID: 10329432

3

Mmh/Ogg1 gene inactivation results in accumulation of 8-hydroxyguanine in mice.

Minowa O, Arai T, Hirano M, Monden Y, Nakai S, Fukuda M, Itoh M, Takano H, Hippou Y, Aburatani H, Masumura K, Nohmi T, Nishimura S, Noda T. Minowa O, et al. Among authors: monden y. Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4156-61. doi: 10.1073/pnas.050404497. Proc Natl Acad Sci U S A. 2000. PMID: 10725358 Free PMC article.

4

A mutant Escherichia coli tyrosyl-tRNA synthetase utilizes the unnatural amino acid azatyrosine more efficiently than tyrosine.

Hamano-Takaku F, Iwama T, Saito-Yano S, Takaku K, Monden Y, Kitabatake M, Soll D, Nishimura S. Hamano-Takaku F, et al. Among authors: monden y. J Biol Chem. 2000 Dec 22;275(51):40324-8. doi: 10.1074/jbc.M003696200. J Biol Chem. 2000. PMID: 11006270 Free article.

5

Azatyrosine. Mechanism of action for conversion of transformed phenotype to normal.

Monden Y, Hamano Takaku F, Shindo Okada N, Nishimura S. Monden Y, et al. Ann N Y Acad Sci. 1999;886:109-21. doi: 10.1111/j.1749-6632.1999.tb09406.x. Ann N Y Acad Sci. 1999. PMID: 10667209 Review.

6

Cloning of the RhoB gene from the mouse genome and characterization of its promoter region.

Nakamura T, Asano M, Shindo-Okada N, Nishimura S, Monden Y. Nakamura T, et al. Among authors: monden y. Biochem Biophys Res Commun. 1996 Sep 24;226(3):688-94. doi: 10.1006/bbrc.1996.1415. Biochem Biophys Res Commun. 1996. PMID: 8831676

7

Azatyrosine inhibits the activation of c-Raf-1, c-Jun and AP1 but not the activation of Ras during signal transduction triggered by oncogenic c-ErbB-2.

Monden Y, Nakamura T, Kojiri K, Shindookada N, Nishimura S. Monden Y, et al. Oncol Rep. 1996 Jan;3(1):33-40. doi: 10.3892/or.3.1.33. Oncol Rep. 1996. PMID: 21594311

8

Azatyrosine is incorporated into proteins instead of tyrosine residues, with the resultant conversion of transformed cells to cells with a normal phenotype.

Monden Y, Nakamura T, Kojiri K, Shindookada N, Nishimura S. Monden Y, et al. Oncol Rep. 1996 Jul;3(4):625-9. doi: 10.3892/or.3.4.625. Oncol Rep. 1996. PMID: 21594424

9

[Mechanism of action of azatyrosine: recent process].

Monden Y, Shindo-Okada N, Nishimura S. Monden Y, et al. Gan To Kagaku Ryoho. 1997 Sep;24(11):1563-70. Gan To Kagaku Ryoho. 1997. PMID: 9309155 Review. Japanese.

10

Stimulation of the expression of rhoB contributes to the ability of azatyrosine to convert c-erbB-2-transformed cells to a normal morphology.

Monden Y, Nakamura T, Kojiri K, Shindookada N, Nishimura S. Monden Y, et al. Oncol Rep. 1996 Jan;3(1):49-55. doi: 10.3892/or.3.1.49. Oncol Rep. 1996. PMID: 21594314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

430 results

Search Page

Filters